Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-09

FDA Approved: ZAVZPRET — Original Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved the original application for Zavzpret (zavegepant) from Pfizer Inc. for the treatment of migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZAVZPRET (zavegepant)

Snippet

ORIG AP for ZAVZPRET (ZAVEGEPANT)